|  

UCB's CIMZIA(R) (certolizumab pegol) Approved by the US FDA for ... - PR Newswire (press release)

Submitted by Editor on Thu, 05/14/2009 - 16:43

UCB's CIMZIA(R) (certolizumab pegol) Approved by the US FDA for ... - PR Newswire (press release) - UCB's CIMZIA(R) (certolizumab pegol) Approved by the US FDA for ...PR Newswire (press release), NYIn the pivotal clinical trials, reported serious adverse reactions were infections including tuberculosis and malignancies including lymphoma. The most commonly occurring adverse events were upper respiratory tract infections, rash and urinary tract ... [Google TB NEWS]